LIVE

Serial Number

78979977

Owner

JOINCARE PHARMACEUTICAL GROUP INDUSTRY CO., LTD.

Attorney

Albert L. Schmeiser

First Use Date

Jan 30, 1999

Filing Date

Dec 28, 2005

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

Serial #78979977 Trademark

Serial Number: 78979977 • Registration: 3546975

Serial #78979977 is a trademark filed by JOINCARE PHARMACEUTICAL GROUP INDUSTRY CO., LTD. on December 28, 2005. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

JOINCARE PHARMACEUTICAL GROUP INDUSTRY CO., LTD. (9 trademarks)

JOINCARE PHARMACEUTICAL BUILDING 17
SHENZHEN CITY, GUANGDONG PROVINCE 518000 , CN

Entity Type: 03

Legal Representation

Attorney of Record

Albert L. Schmeiser

1,285 trademarks filed View all →

Trademark Details

Filing Date

December 28, 2005

Registration Date

December 16, 2008

First Use Anywhere

January 30, 1999

First Use in Commerce

January 30, 1999

Published for Opposition

September 30, 2008

Goods & Services

Non-medical nutritional liquid for beautifying purposes and for human consumption, namely, dietary supplemental drinks; nutritional supplements, namely, spirulina; loquat syrup

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Nov 24, 2018 NA89

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Nov 24, 2018 RNL1

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Nov 24, 2018 89AG

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Nov 24, 2018 APRE

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Nov 14, 2018 TCCA

TEAS SECTION 8 & 9 RECEIVED

Nov 14, 2018 E89R

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Dec 16, 2017 REM2

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Jul 7, 2015 NA85

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Jul 7, 2015 C15A

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Jul 7, 2015 APRE

TEAS SECTION 8 & 15 RECEIVED

Jun 15, 2015 E815

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Dec 18, 2012 TCCA

REGISTERED-PRINCIPAL REGISTER

Dec 16, 2008 R.PR

PUBLISHED FOR OPPOSITION

Sep 30, 2008 PUBO

NOTICE OF PUBLICATION

Sep 10, 2008 NPUB

LAW OFFICE PUBLICATION REVIEW COMPLETED

Aug 26, 2008 PREV

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 25, 2008 CNSA

UNRESPONSIVE/DUPLICATE PAPER RECEIVED

Apr 16, 2008 UNPR

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 16, 2008 CRFA

UNRESPONSIVE/DUPLICATE PAPER RECEIVED

Apr 11, 2008 UNPR

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 11, 2008 CRFA

ASSIGNED TO LIE

Apr 11, 2008 ALIE

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

Apr 11, 2008 GEAN

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

Apr 11, 2008 GEAP

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

Apr 11, 2008 CPEA

NOTICE OF DESIGN SEARCH CODE MAILED

Mar 22, 2008 MDSC

DIVISIONAL PROCESSING COMPLETE

Mar 21, 2008 DPCC

AMENDMENT FROM APPLICANT ENTERED

Mar 18, 2008 ACEC

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 18, 2008 CRFA

DIVISIONAL REQUEST RECEIVED

Mar 14, 2008 DRRR

PAPER RECEIVED

Mar 14, 2008 MAIL

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 14, 2007 GNRN

NON-FINAL ACTION E-MAILED

Sep 14, 2007 GNRT

NON-FINAL ACTION WRITTEN

Sep 14, 2007 CNRT

AMENDMENT FROM APPLICANT ENTERED

Aug 24, 2007 ACEC

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 24, 2007 CRFA

PAPER RECEIVED

Aug 23, 2007 MAIL

NON-FINAL ACTION E-MAILED

Feb 21, 2007 GNRT

NON-FINAL ACTION WRITTEN

Feb 21, 2007 CNRT

AMENDMENT FROM APPLICANT ENTERED

Jan 30, 2007 ACEC

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 30, 2007 CRFA

ASSIGNED TO LIE

Jan 26, 2007 ALIE

PAPER RECEIVED

Dec 28, 2006 MAIL

NON-FINAL ACTION E-MAILED

Jun 28, 2006 GNRT

NON-FINAL ACTION WRITTEN

Jun 28, 2006 CNRT

ASSIGNED TO EXAMINER

Jun 22, 2006 DOCK

NOTICE OF DESIGN SEARCH CODE MAILED

Jan 6, 2006 MDSC

NEW APPLICATION ENTERED

Jan 5, 2006 NWAP

Related Trademarks

More from this Owner

Serial #78781920

YI KE TIE

More in Same Class

MASTBIOMEDICAL

ACHEV